Company intelligence / Profile preview

Antidote Technologies

North Miami Beach, Florida, United Statesantidote.me ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Antidote Technologies operates a digital platform that uses structured data and proprietary algorithms to match patients with suitable clinical trials. The company partners with sponsors in pharma and biotech to accelerate patient recruitment for studies globally. It has received industry recognition for its impact on improving access to research participation.

Therapeutic areas: Other
Industry: Contract Research Organization

Partnerships

Collaborates with pharmaceutical companies and CROs as clients/partners but specific names are not listed in public sources.

Beyond the preview

Go deeper on Antidote Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antidote Technologies.

Explore the full profile